Table 6. Urine Analysis.
Placebo | Supplement | |||||||||
MEN | WOMEN | MEN | WOMEN | Training Effect | Sex Effect | |||||
Pre | Post | Pre | Post | Pre | Post | Pre | Post | P value | P value | |
Cr (mg/24 hr) | 43.7±51.8 | 31.9±39.7 | 150±128.1 | 181.3±145.5 | 66±62.6 | 1851.1± 933.5* | 171.4±153.9 | 2393.7± 1656* | 0.0002 | 0.11 |
Crn (mg/24 hr) | 1265.6±284.0 | 1293.2±217.0 | 978.3±258.2 | 979.0±123.8 | 1432.1±363.2 | 1808.0±544.0* | 935.9±158.8 | 1034.1± 31.6* | 0.002 | 0.0001 |
Crn Cl. (mL/sec) | 1.51±0.36 | 1.54±0.32 | 1.44±0.44 | 1.49±0.36 | 1.72±0.65 | 1.70±0.71 | 1.39±0.33 | 1.40±0.45 | 0.73 | 0.21 |
Cr/Crn ratio | 0.04±0.05 | 0.02±0.03 | 0.16±0.14 | 0.19±0.17 | 0.05±0.06 | 1.11±1.24* | 0.18±0.16 | 2.24±1.52* | 0.0003 | 0.009 |
8-OH/Crn (ng/g Crn) | 8329±3032 | 7394±1921 | 11622±4379 | 10713±3190 | 7245±2703 | 6130±1260 | 7942±3071 | 7088±2582 | 0.01 | 0.03 |
8-iso/Crn (pg/mg Crn) | 2.9±1.3 | 3.8±1.0 | 3.8±1.3 | 4.1±2.1 | 2.5±2.2 | 2.3±1.4 | 5.2±2.3 | 9.9±6.2‡ | 0.03 | 0.005 |
N-telo (BCE/mmol Crn) | 380.6±335.7 | 378.1±275.6 | 354.7±231.3 | 235.9±146.5 | 510±353.3 | 712.4±714.4 | 257.7±79.7 | 272.1±154.2 | 0.67 | 0.09 |
Values are means±standard deviation. 8-OH = 8-hydroxy-2-deoxyguanosine; 8-Iso. = 8-isoprostane per 24 hour urine; Cr = Creatine; Crn = creatinine; Cl. = Clearance; N-telo = N-telopeptides; BCE = bone collagen equivalent.
indicates a significant interaction between training and supplement (see text).
indicates a significant interaction between training, supplement and gender (see text).